Heart-1 Gene Therapy Trial Pauses Enrollment
Enrolment in a clinical trial of a gene editing therapy for patients with heterozygous familial hypercholesterolemia has been paused after laboratory abnormalities were detected in one participant. The therapy, VERVE-101,…
10 Best Shampoos For Oily Hair In 2024: How To Beat The Grease
When selecting a shampoo for oily hair, it is important to consider factors such as ingredients, hair type, and specific concerns like dandruff or scalp irritation. Look for clarifying shampoos…
Insulin resistance before diabetes onset may increase risk of albuminuria after diabetes onset: Study
A recent study found that individuals with insulin resistance before developing diabetes may have a higher risk of developing albuminuria, a condition where the kidneys leak abnormal amounts of protein…
Amylyx Withdraws ALS Drug From Market; Restructuring Will Slash 70% of Staff
Amylyx Pharmaceuticals is voluntarily withdrawing its drug Relyvrio, used to treat amyotrophic lateral sclerosis (ALS), from the market after clinical trial results showed it was no better than a placebo.…
General Practitioner – Swanlinbar, Co. Cavan
Community Healthcare in Cavan, Donegal, Leitrim, Monaghan, located in Swanlinbar, Co. Cavan, is seeking applications for a position. The application form can be obtained by contacting Fiona Monahan, GP Services…
Pager Health announces three new generative AI apps
Pager Health has developed three generative AI applications for payers, Chat Summation, FAQ Bot, and Sentiment Analysis, built on Google Cloud. These tools aim to streamline patient interactions, provide administrative…
Unauthorized Sign-Ups Cast Shadow on Obamacare’s Record Enrollment
The Biden administration is facing an issue with disreputable insurance brokers enrolling people in the Affordable Care Act's insurance exchange without their authorization. Michael Debriae, a restaurant server, was enrolled…
Options other than medications needed for 24/7 IOP control
Dr. Analisa Arosemena discussed the benefits of canaloplasty in achieving 24/7 IOP control for glaucoma patients, highlighting the drawbacks of medication as a treatment due to toxicity and compliance issues.…
Readout Newsletter: Amylyx, Parkinson’s, Moderna updates
The need-to-know this morning includes Amylyx Pharmaceuticals removing its ALS treatment from the market after it failed to show benefits in a clinical trial. A study suggests a GLP-1 drug…
Autism and ADHD place “unprecedented” demand on NHS
The rise in the number of people in England waiting for diagnosis and treatment of autism and ADHD has led to a need for a reorganization of services, including involvement…